Strive (NASDAQ:ASST) finalized its acquisition of Semler Scientific on Jan. 16, a merger that significantly expands its digital asset reserves and pivots the firm toward a dual-focus strategy of Bitcoin treasury management and medical technology.
Following the close, Strive now controls approximately 12,797.9 bitcoin.
The consolidated treasury positions the company as the 11th largest public corporate holder of bitcoin globally, placing it among a high-profile cohort of institutional accumulators.
The move reflects Strive's "Bitcoin-first" corporate philosophy, where the cryptocurrency serves as the primary reserve asset to protect against long-term currency debasement.
To manage the newly integrated healthcare operations, Strive has appointed Avik Roy as Chief Strategy Officer.
Roy, a veteran of Bain Capital and a prominent figure in healthcare policy at the Foundation for Research on Equal Opportunity, will transition from his role as an independent board member to a full-time executive position.
His primary mandate is to monetize and scale Semler Scientific’s core business, specifically its FDA-cleared QuantaFlo® system used for the early detection of peripheral arterial disease (PAD).
The leadership overhaul also includes the addition of Eric Semler, former chairman of Semler Scientific, to Strive’s board as an independent member.
Further cementing its commitment to the digital asset space, the company named Joe Burnett—previously Semler’s head of bitcoin strategy—as Vice President of Bitcoin Strategy.
Under the new structure, Strive intends to use the cash flows generated by Semler’s medical diagnostic products to further expand its bitcoin holdings.